These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17219276

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M, Wu N, Liu Y, Zheng R, Liang Y, Zhang W, Zhao P.
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR.
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
    Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, Vallières E, Wood DE.
    J Thorac Oncol; 2008 Sep; 3(9):971-8. PubMed ID: 18758298
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?
    Kim TJ, Park CM, Goo JM, Lee KW.
    AJR Am J Roentgenol; 2012 Jan; 198(1):83-8. PubMed ID: 22194482
    [Abstract] [Full Text] [Related]

  • 55. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I, Sivrikoz MC, Entok E, Vardareli E.
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [Abstract] [Full Text] [Related]

  • 56. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
    Kurtipek E, Çayci M, Düzgün N, Esme H, Terzi Y, Bakdik S, Aygün MS, Unlü Y, Burnik C, Bekci TT.
    Clin Nucl Med; 2015 Jun; 40(6):459-63. PubMed ID: 25742234
    [Abstract] [Full Text] [Related]

  • 57. Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management.
    Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG.
    Ann Thorac Surg; 2015 Feb; 99(2):414-20. PubMed ID: 25497068
    [Abstract] [Full Text] [Related]

  • 58. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
    Stevens H, Bakker PF, Schlösser NJ, van Rijk PP, de Klerk JM.
    J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.